Ligand id: 6887

Name: belimumab

IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: belimumab

Compound class Antibody
Approved drug? Yes (FDA (2011), EMA (2011))
International Nonproprietary Names
INN number INN
8381 belimumab
Benlysta® | hBlySmAb-1.1 | LimphoStat-B | lymphostat-B
Belimumab is a monoclonal antibody targeting TNFSF13B (BAFF; BLyS) [1,4] , an immunostimulant essential for normal B cell maintenance and humoral immunity [5], and which is reported to be elevated in systemic lupus erythematosus (SLE) and other autoimmune diseases
Database Links
Specialist databases
IMGT/mAb-DB 266
Other databases
GtoPdb PubChem SID 178103469
PubChem SID 178103469
Search PubMed clinical trials belimumab
Search PubMed titles belimumab
Search PubMed titles/abstracts belimumab
Wikipedia Belimumab